Trial NCT00819910

View at ClinicalTrials.gov 
Org. Study IDs: C.2007.122

Last trial update was posted on 2014-04-24

MeSH Interventions

Fenofibrate Rosiglitazone

MeSH Conditions

Hyperlipidemias Hyperlipoproteinemias Hypertriglyceridemia

Other Conditions

Hypertriglyceridemia in Type 4 Hyperlipidemia Non Diabetic Subjects With Normoglycemia

Stopping Reasons

Slow recruitment and increase in deployment overseas limiting follow up

Limitations And Caveats

First, the study was terminated early per FDA recommendations restricting rosiglitazone use. Second, recruitment of patients was slow due to deployment restraints.

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID